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Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa
Combination therapy with several antibiotics is one strategy that has been applied in order to limit the spread of
antimicrobial resistance. We compared the de novo evolution of resistance during combination therapy with the β-lactam
ceftazidime and the fluoroquinolone ciprofloxacin with the resistance evolved after single-drug exposure. Combination
therapy selected for mutants that displayed broad-spectrum resistance, and a major resistance mechanism was
mutational inactivation of the repressor gene mexR that regulates the multidrug efflux operon mexAB–oprM. Deregulation
of this operon led to a broad-spectrum resistance phenotype that decreased susceptibility to the combination of drugs
applied during selection as well as to unrelated antibiotic classes. Mutants isolated after single-drug exposure displayed
narrow-spectrum resistance and carried mutations in the MexCD–OprJ efflux pump regulator gene nfxB conferring
ciprofloxacin resistance, or in the gene encoding the non-essential penicillin-binding protein DacB conferring ceftazidime
resistance. Reconstruction of resistance mutations by allelic replacement and in vitro fitness assays revealed that in
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